- Home
- CHRW vs NBIX Comparison
CHRW vs NBIX Comparison
Compare CHRW & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- NBIX
- Stock Information
- Founded
- CHRW 1905
- NBIX 1992
- Country
- CHRW United States
- NBIX United States
- Employees
- CHRW N/A
- NBIX N/A
- Industry
- CHRW Oil Refining/Marketing
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHRW Consumer Discretionary
- NBIX Health Care
- Exchange
- CHRW Nasdaq
- NBIX Nasdaq
- Market Cap
- CHRW 14.8B
- NBIX 14.4B
- IPO Year
- CHRW 1997
- NBIX 1996
- Fundamental
- Price
- CHRW $125.78
- NBIX $144.18
- Analyst Decision
- CHRW Buy
- NBIX Strong Buy
- Analyst Count
- CHRW 21
- NBIX 18
- Target Price
- CHRW $132.15
- NBIX $165.78
- AVG Volume (30 Days)
- CHRW 1.4M
- NBIX 814.9K
- Earning Date
- CHRW 10-29-2025
- NBIX 10-28-2025
- Dividend Yield
- CHRW 1.98%
- NBIX N/A
- EPS Growth
- CHRW 58.22
- NBIX 2.97
- EPS
- CHRW 4.40
- NBIX 3.39
- Revenue
- CHRW $17,012,580,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- CHRW N/A
- NBIX $20.79
- Revenue Next Year
- CHRW $3.64
- NBIX $14.73
- P/E Ratio
- CHRW $28.51
- NBIX $42.39
- Revenue Growth
- CHRW N/A
- NBIX 18.42
- 52 Week Low
- CHRW $84.68
- NBIX $84.23
- 52 Week High
- CHRW $138.00
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- CHRW 41.57
- NBIX 61.70
- Support Level
- CHRW $125.76
- NBIX $136.71
- Resistance Level
- CHRW $130.16
- NBIX $140.73
- Average True Range (ATR)
- CHRW 2.95
- NBIX 3.22
- MACD
- CHRW -0.66
- NBIX 0.44
- Stochastic Oscillator
- CHRW 18.36
- NBIX 94.79
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.